| Serine is a new target residue for endogenous ADP-ribosylation on histones O Leidecker, JJ Bonfiglio, T Colby, Q Zhang, I Atanassov, R Zaja, ... Nature chemical biology 12 (12), 998-1000, 2016 | 219 | 2016 |
| Serine is the major residue for ADP-ribosylation upon DNA damage L Palazzo, O Leidecker, E Prokhorova, H Dauben, I Matic, I Ahel Elife 7, e34334, 2018 | 205 | 2018 |
| Serine ADP-ribosylation reversal by the hydrolase ARH3 P Fontana, JJ Bonfiglio, L Palazzo, E Bartlett, I Matic, I Ahel Elife 6, e28533, 2017 | 200 | 2017 |
| Processing of Protein ADP-ribosylation by Nudix Hydrolases L Palazzo, B Thomas, AS Jemth, T Colby, O Leidecker, K Feijs, R Zaja, ... Biochemical Journal, 2015 | 140 | 2015 |
| ADP‐ribosylation: new facets of an ancient modification L Palazzo, A Mikoč, I Ahel The FEBS journal 284 (18), 2932-2946, 2017 | 135 | 2017 |
| (ADP-ribosyl) hydrolases: structure, function, and biology JGM Rack, L Palazzo, I Ahel Genes & development 34 (5-6), 263-284, 2020 | 121 | 2020 |
| ADP-ribosylation signalling and human disease L Palazzo, P Mikolčević, A Mikoč, I Ahel Open biology 9 (4), 190041, 2019 | 88 | 2019 |
| ENPP1 processes protein ADP‐ribosylation in vitro L Palazzo, CM Daniels, JE Nettleship, N Rahman, RL McPherson, ... The FEBS journal 283 (18), 3371-3388, 2016 | 74 | 2016 |
| Fcp1-dependent dephosphorylation is required for M-phase-promoting factor inactivation at mitosis exit R Visconti, L Palazzo, R Della Monica, D Grieco Nature communications 3 (1), 894, 2012 | 70 | 2012 |
| PARPs in genome stability and signal transduction: implications for cancer therapy L Palazzo, I Ahel Biochemical Society Transactions 46 (6), 1681-1695, 2018 | 65 | 2018 |
| Unrestrained poly-ADP-ribosylation provides insights into chromatin regulation and human disease E Prokhorova, T Agnew, AR Wondisford, M Tellier, N Kaminski, D Beijer, ... Molecular Cell 81 (12), 2640-2655. e8, 2021 | 59 | 2021 |
| Progress and outlook in studying the substrate specificities of PARPs and related enzymes MJ Suskiewicz, L Palazzo, R Hughes, I Ahel The FEBS Journal 288 (7), 2131-2142, 2021 | 49 | 2021 |
| MacroD1 is a promiscuous ADP-ribosyl hydrolase localized to mitochondria T Agnew, D Munnur, K Crawford, L Palazzo, A Mikoč, I Ahel Frontiers in microbiology 9, 20, 2018 | 45 | 2018 |
| The Fcp1-Wee1-Cdk1 axis affects spindle assembly checkpoint robustness and sensitivity to antimicrotubule cancer drugs R Visconti, R Della Monica, L Palazzo, F D'alessio, M Raia, S Improta, ... Cell Death & Differentiation 22 (9), 1551-1560, 2015 | 43 | 2015 |
| ATM controls proper mitotic spindle structure L Palazzo, R Della Monica, R Visconti, V Costanzo, D Grieco Cell Cycle 13 (7), 1091-1100, 2014 | 38 | 2014 |
| Role for non-proteolytic control of M-phase promoting factor activity at M-phase exit V D'Angiolella, L Palazzo, C Santarpia, V Costanzo, D Grieco PLoS One 2 (2), e247, 2007 | 37 | 2007 |
| Requirement for proteolysis in spindle assembly checkpoint silencing R Visconti, L Palazzo, D Grieco Cell Cycle 9 (3), 564-569, 2010 | 33 | 2010 |
| PARPs and PAR as novel pharmacological targets for the treatment of stress granule-associated disorders G Grimaldi, G Catara, L Palazzo, A Corteggio, C Valente, D Corda Biochemical Pharmacology 167, 64-75, 2019 | 26 | 2019 |
| Serine ADP-ribosylation in DNA-damage response regulation L Palazzo, MJ Suskiewicz, I Ahel Current Opinion in Genetics & Development 71, 106-113, 2021 | 23 | 2021 |
| Targeting ADP-ribosylation as an antimicrobial strategy G Catara, A Corteggio, C Valente, G Grimaldi, L Palazzo Biochemical Pharmacology 167, 13-26, 2019 | 22 | 2019 |
Ivan AhelUniversity of OxfordVerified email at path.ox.ac.uk
